Cargando…

Baseline Serum Uric Acid Levels Are Associated with All-Cause Mortality in Acute Coronary Syndrome Patients after Percutaneous Coronary Intervention

BACKGROUND: Whether serum uric acid (UA) is associated with all-cause mortality in patients with acute coronary syndrome (ACS) following percutaneous coronary intervention (PCI) remains unclear. METHODS: We performed a retrospective cohort study of 2296 patients with ACS. Curve-fitting and Cox propo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Ziliang, Lu, Haili, Long, Manyun, Li, Lang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311730/ https://www.ncbi.nlm.nih.gov/pubmed/30647801 http://dx.doi.org/10.1155/2018/9731374

Ejemplares similares

Efficacy and safety of nicorandil on perioperative myocardial injury in patients undergoing elective percutaneous coronary intervention: results of the PENMIPCI trial
por: Ye, Ziliang, et al.
Publicado: (2018)

Dual anti-platelet therapy following percutaneous coronary intervention in a population of patients with thrombocytopenia at baseline: a meta-analysis
por: Long, Manyun, et al.
Publicado: (2020)

Reduced Left Ventricular Ejection Fraction Is a Risk Factor for In-Hospital Mortality in Patients after Percutaneous Coronary Intervention: A Hospital-Based Survey
por: Ye, Ziliang, et al.
Publicado: (2018)

Effect of high-dose rosuvastatin loading before percutaneous coronary intervention in Chinese patients with acute coronary syndrome: A systematic review and meta-analysis
por: Ye, Ziliang, et al.
Publicado: (2017)

Uric acid variability at midlife as an independent predictor of coronary heart disease and all-cause mortality
por: Grossman, Chagai, et al.
Publicado: (2019)

The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients: A systematic review and meta-analysis
por: Ye, Ziliang, et al.
Publicado: (2016)

Prognostic Value of Different Levels of Uric Acid in Patients with Coronary Chronic Total Occlusion Undergoing Percutaneous Coronary Intervention
por: Ayoub, Mohamed, et al.
Publicado: (2023)

Effects of Percutaneous Coronary Intervention on Serum Angiopoietin-2 in Patients with Coronary Heart Disease
por: Zeng, Zhi-Yu, et al.
Publicado: (2016)

Association of serum uric acid with all-cause and cardiovascular mortality in obstructive sleep apnea
por: Yang, Zhe, et al.
Publicado: (2023)

Dose‐dependent effect of impaired renal function on all‐cause mortality in patients following percutaneous coronary intervention
por: Limpijankit, Thosaphol, et al.
Publicado: (2022)

Prediction of All-Cause Mortality Following Percutaneous Coronary Intervention in Bifurcation Lesions Using Machine Learning Algorithms
por: Burrello, Jacopo, et al.
Publicado: (2022)

Inter-Ethnic Differences in Quantified Coronary Artery Disease Severity and All-Cause Mortality among Dutch and Singaporean Percutaneous Coronary Intervention Patients
por: Gijsberts, Crystel M., et al.
Publicado: (2015)

Impact of serum uric acid levels on the clinical prognosis and severity of coronary artery disease in patients with acute coronary syndrome and hypertension after percutaneous coronary intervention: a prospective cohort study
por: Zhang, Shiyu, et al.
Publicado: (2022)

Impact of percutaneous coronary intervention on patients with impaired baseline renal function
por: Yadav, Deepti, et al.
Publicado: (2020)

The platelet-to-lymphocyte ratio as a predictor of all-cause mortality in patients with coronary artery disease undergoing elective percutaneous coronary intervention and stent implantation
por: Osadnik, Tadeusz, et al.
Publicado: (2015)

Association of Serum Uric Acid Concentration and Its Change with Cardiovascular Death and All-Cause Mortality
por: Dong, Ze-Xuan, et al.
Publicado: (2020)

Associations of Lipoprotein(a) With Coronary Atherosclerotic Burden and All-Cause Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
por: Xue, Yuzhou, et al.
Publicado: (2021)

The U-Shaped Relationship Between Serum Uric Acid and Long-Term All-Cause Mortality in Coronary Artery Disease Patients: A Cohort Study of 33,034 Patients
por: Zheng, Yiying, et al.
Publicado: (2022)

Normal thyroid stimulating hormone is associated with all-cause mortality in patients with acute myocardial infarction after percutaneous coronary intervention
por: Ni, Wei-cheng, et al.
Publicado: (2023)

Visit-to-visit variability of serum uric acid measurements and the risk of all-cause mortality in the general population
por: Tian, Xue, et al.
Publicado: (2021)

The association between the serum uric acid to creatinine ratio and all-cause mortality in elderly hemodialysis patients
por: Ding, Zhihui, et al.
Publicado: (2022)

Elevated Baseline Serum Fibrinogen: Effect on 2‐Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention
por: Ang, Lawrence, et al.
Publicado: (2017)

Association of Serum Uric Acid and Coronary Artery Disease in Premenopausal Women
por: Zhang, Jian-wei, et al.
Publicado: (2014)

Serum Uric Acid Is Independently Associated with Coronary Calcification in an Asymptomatic Population
por: Kiss, Loretta Zsuzsa, et al.
Publicado: (2018)

The Associations of Uric Acid, Cardiovascular and All-Cause Mortality in Peritoneal Dialysis Patients
por: Dong, Jie, et al.
Publicado: (2014)

Effects of Baseline Thrombocytopenia on In-hospital Outcomes in Patients Undergoing Elective Percutaneous Coronary Intervention
por: Shiraishi, Jun, et al.
Publicado: (2019)

Association between Uric Acid and In-Hospital Heart Failure in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
por: Liu, Cun-Fei, et al.
Publicado: (2021)

Association of admission hyperglycemia and all-cause mortality in acute myocardial infarction with percutaneous coronary intervention: A dose–response meta-analysis
por: Cheng, Shao-Yong, et al.
Publicado: (2022)

Early percutaneous coronary intervention and in-hospital mortality in non st elevation coronary syndromes
por: Cebrián Domenech, J, et al.
Publicado: (2015)

Relationship between serum uric acid and all-cause mortality in dialysis patients: like being in wonderland, disoriented
por: Zhao, Yu, et al.
Publicado: (2020)

Cumulative Serum Uric Acid and Its Time Course Are Associated With Risk of Myocardial Infarction and All‐Cause Mortality
por: Tian, Xue, et al.
Publicado: (2021)

Change in Serum Uric Acid is a Useful Predictor of All-Cause Mortality among Community-Dwelling Persons
por: Kawamoto, Ryuichi, et al.
Publicado: (2023)

Serum uric acid to creatinine ratio is a useful predictor of all-cause mortality among hypertensive patients
por: Kawamoto, Ryuichi, et al.
Publicado: (2023)

Impact of diabetes on long-term all-cause re-hospitalization after revascularization with percutaneous coronary intervention
por: Hansen, Kirstine N, et al.
Publicado: (2022)

The significance of follow‐up serum uric acid levels in predicting all‐cause mortality and cardiovascular mortality in peritoneal dialysis patients
por: Wang, Yaomin, et al.
Publicado: (2022)

Should Percutaneous Coronary Intervention be the Standard Treatment Strategy for Significant Coronary Artery Disease in all Octogenarians?
por: Kassimis, George, et al.
Publicado: (2021)

Effect of preoperative loading dose ticagrelor and clopidogrel on no-reflow phenomenon during intervention in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis
por: Dai, Weiran, et al.
Publicado: (2018)

Percutaneous Coronary Intervention on Right Coronary Artery With All Coronary Arteries From Three Separate Ostiums in the Right Sinus of Valsalva
por: Sayin, Muhammet Rasit, et al.
Publicado: (2011)

Long-term effects of baseline on-treatment platelet reactivity in patients with acute coronary syndrome and thrombocytopenia undergoing percutaneous coronary intervention
por: Liu, Ru, et al.
Publicado: (2022)

Clinical Value of Serum Uric Acid in Patients with Suspected Coronary Artery Disease
por: Lim, Hong Euy, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_tgaeh29a324vm45il6fnngnamh